Article
How long until it's all over?
We can't say for sure, but everything depends on how many people agree to be vaccinated.
Rachel Thomas
Article
Who should be vaccinated first?
Modelling shows that old and vulnerable people should be prioritised.
Article
How were the vaccines tested?
Like any medical drug, vaccines are tested in large-scale randomised controlled trials.
Article
How effective are the vaccines — and how do we know this?
The efficacy of vaccines is estimated from trials, using statistical techniques.
Article
Since herd immunity will protect us all, why do I need to get vaccinated?
Because the vaccine may not stop transmission of the virus.
Article
Are the vaccines safe?
Yes the approved vaccines are safe. If you balance the risks, then taking the vaccine is much safer than taking your chances with COVID-19.
Article
What's the price for relaxing the rules?
We are all longing to go into a lower tier, but this can come at a high price later on.
Article
The agent perspective
How do we learn and understand the world? What separates us from machines? Yoshua Bengio believes it all comes down to our agency.
Article
Building meaning: dog or ostrich
How do we build our models of the world? Yoshua Bengio explains how deep learning will help machines act to understand the world in a similar way.
Article
The growth rate of COVID-19
We all now know about R, but sometimes it can be good to consider another number: the growth rate of an epidemic.
Article
The maths behind combining R ratios
In a previous article we introduced the problems that can arise when combine the reproduction ratios of a disease in different settings, such as hospitals and the community. In this article we dive into the maths that helps you get to the bottom of these problems.
Article
The problem with combining R ratios
We explore why you need to be extremely careful when combining the reproduction ratios of a disease in different settings, such as hospitals and the community.